Dirk Arnold's guest appearances

Dirk Arnold

Gastrointestinal Cancer Update

Future Science Group

Philip A Philip

Michael Merzenich

David Harris

Gareth Mitchell

Andrew X

Axel Grothey

Alan P Venook

Scott Kopetz

Zev Wainberg

Peter C Enzinger

Yelena Y Janjigian

Anthony El-Khoueiry

Gigi Qiqi Chen

Margaret Deutsch

Bert H

OwlTail

In this podcast, Jade Parker, Editor of Oncology Central speaks to Dirk Arnold. Dirk Arnold is Director of the Dept. Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg and Berlin.His major field of scientific interest are gastrointestinal cancers, and here specifically modern therapeutic approaches in biomarker-driven decision processes and multimodal treatment strategies.In this interview find out about the main treatment options for  oligometastic rectal cancer and how we can define a treatment strategy for this disease. Prof Arnold also tells us how he hopes to see the field progress in the next 5-10 years.You can view more podcasts, plus the latest news and interviews with experts across oncology at www.oncology-central.com.

In this podcast, Jade Parker, Editor of Oncology Central speaks to Dirk Arnold. Dirk Arnold is Director of the Dept. Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg and Berlin. His major field of scientific interest are gastrointestinal cancers, and here specifically modern therapeutic approaches in biomarker-driven decision processes and multimodal treatment strategies. In this interview find out about the main treatment options for oligometastic rectal cancer and how we can define a treatment strategy for this disease. Prof Arnold also tells us how he hopes to see the field progress in the next 5-10 years. You can view more podcasts, plus the latest news and interviews with experts across oncology at <a href="http://www.oncology-central.com" rel="nofollow" target="_blank">www.oncology-central.com</a>.

OCTalks: Defining a strategy for oligometastic rectal cancer: an interview with Dirk Arnold

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Dirk Arnold, MD conducted by Neil Love, MD. Produced by Research To Practice.

GICU1 2012 | Interview with Dirk Arnold, MD